Leo van der Pol

1.1k total citations
11 papers, 860 citations indexed

About

Leo van der Pol is a scholar working on Molecular Biology, Epidemiology and Microbiology. According to data from OpenAlex, Leo van der Pol has authored 11 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Microbiology. Recurrent topics in Leo van der Pol's work include Protein purification and stability (5 papers), Bacterial Infections and Vaccines (4 papers) and Pneumonia and Respiratory Infections (3 papers). Leo van der Pol is often cited by papers focused on Protein purification and stability (5 papers), Bacterial Infections and Vaccines (4 papers) and Pneumonia and Respiratory Infections (3 papers). Leo van der Pol collaborates with scholars based in Netherlands, United States and Austria. Leo van der Pol's co-authors include Michiel Stork, Peter van der Ley, Dirk E. Martens, René H. Wijffels, Matthias J. H. Gerritzen, J. Tramper, Mathieu Streefland, Bas van de Waterbeemd, Harry van Dijken and Bert Zomer and has published in prestigious journals such as PLoS ONE, Trends in biotechnology and Biotechnology Advances.

In The Last Decade

Leo van der Pol

11 papers receiving 845 citations

Peers

Leo van der Pol

MICRO

EPIDE

IMMUN

Fabiola Giusti Italy

Laura Perez Vidakovics Sweden

Seng Jin Choi South Korea

Hongmei Bai China

Wenzhou Hong United States

Matthias J. H. Gerritzen Netherlands

Elena Caproni Italy

Laura Fantappiè Italy

Caridad Zayas Cuba

María E. Sarmiento Malaysia

Fabiola Giusti Italy

Leo van der Pol

260 ×0.6

MICRO

419 ×1.2

217 ×0.7

EPIDE

158 ×1.0

IMMUN

144 ×1.0

Citations per year, relative to Leo van der Pol Leo van der Pol (= 1×) peers Fabiola Giusti

Countries citing papers authored by Leo van der Pol

Since Specialization

Citations

This map shows the geographic impact of Leo van der Pol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo van der Pol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo van der Pol more than expected).

Fields of papers citing papers by Leo van der Pol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo van der Pol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo van der Pol. The network helps show where Leo van der Pol may publish in the future.

Co-authorship network of co-authors of Leo van der Pol

This figure shows the co-authorship network connecting the top 25 collaborators of Leo van der Pol. A scholar is included among the top collaborators of Leo van der Pol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo van der Pol. Leo van der Pol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Heijden, Joris van der, Leo van der Pol, António Roldão, et al.. (2025). Engineered thermoswitch in the baculovirus expression vector system for production of virus-like particle vaccines with minimized baculovirus contaminants. Trends in biotechnology. 43(7). 1690–1713. 2 indexed citations

Williams, Ann, Bernard Fritzell, Dominick J. Laddy, et al.. (2020). The TB vaccine development pathway – An innovative approach to accelerating global TB vaccine development. Tuberculosis. 126. 102040–102040. 8 indexed citations

Gerritzen, Matthias J. H., Dirk E. Martens, René H. Wijffels, Leo van der Pol, & Michiel Stork. (2017). Bioengineering bacterial outer membrane vesicles as vaccine platform. Biotechnology Advances. 35(5). 565–574. 217 indexed citations

Onu, Adrian, et al.. (2016). Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes. PLoS ONE. 11(3). e0150700–e0150700. 51 indexed citations

Pol, Leo van der, et al.. (2016). Process development of a New Haemophilus influenzae type b conjugate vaccine and the use of mathematical modeling to identify process optimization possibilities. Biotechnology Progress. 32(3). 568–580. 2 indexed citations

Pol, Leo van der, Michiel Stork, & Peter van der Ley. (2015). Outer membrane vesicles as platform vaccine technology. Biotechnology Journal. 10(11). 1689–1706. 282 indexed citations

Blom, Hans, et al.. (2014). Efficient chromatographic reduction of ovalbumin for egg-based influenza virus purification. Vaccine. 32(30). 3721–3724. 29 indexed citations

Waterbeemd, Bas van de, Mathieu Streefland, Peter van der Ley, et al.. (2010). Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process. Vaccine. 28(30). 4810–4816. 150 indexed citations

Waterbeemd, Bas van de, Mathieu Streefland, Jeroen L. A. Pennings, et al.. (2009). Gene‐expression‐based quality scores indicate optimal harvest point in Bordetella pertussis cultivation for vaccine production. Biotechnology and Bioengineering. 103(5). 900–908. 19 indexed citations

10.

Metz, Bernard, Germie van den Dobbelsteen, Cécile A. C. M. van, et al.. (2009). Quality-control issues and approaches in vaccine development. Expert Review of Vaccines. 8(2). 227–238. 38 indexed citations

11.

Pol, Leo van der & J. Tramper. (1998). Shear sensitivity of animal cells from a culture-medium perspective. Trends in biotechnology. 16(8). 323–328. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact